赛诺医疗
(688108)
| 流通市值：83.97亿 | | | 总市值：83.97亿 |
| 流通股本：4.18亿 | | | 总股本：4.18亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 139,735,742.82 | 525,407,851.22 | 363,854,525.58 | 240,476,013.66 |
| 营业收入 | 139,735,742.82 | 525,407,851.22 | 363,854,525.58 | 240,476,013.66 |
| 二、营业总成本 | 110,756,427.78 | 478,178,733.38 | 348,935,582.94 | 234,401,263.96 |
| 营业成本 | 42,179,298.82 | 176,984,928.61 | 124,786,396.64 | 87,427,710.14 |
| 税金及附加 | 1,595,360.13 | 6,245,199.02 | 4,203,503.8 | 2,866,304.24 |
| 销售费用 | 18,094,229.69 | 77,525,348.41 | 54,589,299.32 | 35,499,042.15 |
| 管理费用 | 22,734,629.02 | 90,666,614.72 | 69,380,991.61 | 46,927,417.69 |
| 研发费用 | 25,025,511.31 | 122,570,643.31 | 92,757,264.16 | 59,707,969.51 |
| 财务费用 | 1,127,398.81 | 4,185,999.31 | 3,218,127.41 | 1,972,820.23 |
| 其中:利息费用 | 1,024,354.04 | 5,046,297.84 | 3,863,667.71 | 2,519,833.22 |
| 其中:利息收入 | 466,276.85 | 2,149,854.92 | 1,682,839.07 | 1,261,644.05 |
| 三、其他经营收益 | | | | |
| 资产减值损失(新) | -1,331,438.94 | -3,912,065.46 | 1,081,861.33 | 3,358,349.76 |
| 信用减值损失(新) | -29,649.82 | -265,624.72 | 69,502.93 | -39,528.58 |
| 其他收益 | 2,665,203.18 | 23,753,184.91 | 15,774,889.05 | 11,872,051.17 |
| 四、营业利润 | 30,283,429.46 | 66,804,612.57 | 31,845,195.95 | 21,265,622.05 |
| 加:营业外收入 | 1,297.01 | 2,237,957.33 | 2,259,824.92 | 2,256,291.15 |
| 减:营业外支出 | 125 | 596,655.73 | 588,131.41 | 511,350.83 |
| 五、利润总额 | 30,284,601.47 | 68,445,914.17 | 33,516,889.46 | 23,010,562.37 |
| 减:所得税费用 | 3,204,321.12 | 20,979,971.46 | 12,797,164 | 9,842,151.32 |
| 六、净利润 | 27,080,280.35 | 47,465,942.71 | 20,719,725.46 | 13,168,411.05 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 27,080,280.35 | 47,465,942.71 | 20,719,725.46 | 13,168,411.05 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 24,462,815.54 | 47,286,319.99 | 21,117,988.34 | 13,841,586.81 |
| 少数股东损益 | 2,617,464.81 | 179,622.72 | -398,262.88 | -673,175.76 |
| 扣除非经常损益后的净利润 | 23,121,787.27 | 33,955,505.95 | 13,905,948.87 | 7,977,673.71 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.06 | 0.11 | 0.05 | 0.03 |
| (二)稀释每股收益 | 0.06 | 0.11 | 0.05 | 0.03 |
| 八、其他综合收益 | -808,182.24 | -500,262.11 | 234,158.53 | 761,914.42 |
| 归属于母公司股东的其他综合收益 | -808,182.24 | -500,262.11 | 234,158.53 | 761,914.42 |
| 九、综合收益总额 | 26,272,098.11 | 46,965,680.6 | 20,953,883.99 | 13,930,325.47 |
| 归属于母公司股东的综合收益总额 | 23,654,633.3 | 46,786,057.88 | 21,352,146.87 | 14,603,501.23 |
| 归属于少数股东的综合收益总额 | 2,617,464.81 | 179,622.72 | -398,262.88 | -673,175.76 |
| 公告日期 | 2026-04-29 | 2026-03-26 | 2025-10-31 | 2025-08-22 |
| 审计意见(境内) | | 标准无保留意见 | | |